Skip to content

CARO PHARMA: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

CARO PHARMA

BE 0899.338.864
NACE 47.730, Retail sale of pharmaceutical products
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
-€26,056
2024 · -€81,990+€55,935
Equity
€154,269
2024 · €180,325-€26,056
Cash
€29,891
2024 · €26,783+€3,107
Balance sheet total
€593,057
2024 · €669,636-€76,579

Largest movements

2024 to 2025
Assets
  • Intangible fixed assets -€68,799

    down €68,799 (-16.7%), from €412,517 to €343,718

  • Tangible fixed assets -€9,755

    down €9,755 (-6.4%), from €152,449 to €142,694

    of which Land and buildings: -€8,100

Equity and liabilities
  • Debts after one year -€69,029

    down €69,029 (-28.2%), from €244,674 to €175,645

    of which Financial debts: -€47,206

  • Profit (loss) carried forward -€26,056

    down €26,056 (-20.8%), from €125,325 to €99,269

  • Tax, wage and social debts +€16,786

    up €16,786 (+88.7%), from €18,915 to €35,702

Income statement
  • Taxes -€63,052

    down €63,052 (-79.3%), from €79,510 to €16,459

  • Gross operating margin -€10,052

    down €10,052 (-11.0%), from €91,505 to €81,453

  • Financial charges -€2,798

    down €2,798 (-20.6%), from €13,589 to €10,792

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 -€81,990
Gross operating margin -€10,052
Depreciation +€34
Other operating charges -€93
Financial income +€196
Financial charges +€2,798
Taxes +€63,052
Result 2025 -€26,056
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€71,123
Investment -€393
Financing -€67,623
Cash 2024 €26,783
Net result for the year -€26,056
Depreciation +€78,946
Smaller working-capital items +€171
Receivables within one year +€961
Provisions -€1,449
Trade debts -€3,319
Tax, wage and social debts +€16,786
Accrued charges and deferred income +€5,082
Investment in fixed assets (net) -€393
Debts after one year -€69,029
Current portion of long-term debt +€1,405
Cash 2025 €29,891
brings cash intakes cash out
Every line side by side 48 lines
Line Code 2024 2025 Change %
Total assets 20/58 €669,636 €593,057 -€76,579 -11.4%
Fixed assets 21/28 €564,966 €486,412 -€78,554 -13.9%
Intangible fixed assets 21 €412,517 €343,718 -€68,799 -16.7%
Tangible fixed assets 22/27 €152,449 €142,694 -€9,755 -6.4%
Land and buildings 22 €150,081 €141,981 -€8,100 -5.4%
Plant, machinery and equipment 23 €1,331 €713 -€618 -46.4%
Furniture and vehicles 24 €1,036 - -€1,036
Current assets 29/58 €104,670 €106,645 +€1,975 +1.9%
Stocks and contracts in progress 3 €38,640 €38,477 -€163 -0.4%
Stocks 30/36 €38,640 €38,477 -€163 -0.4%
Amounts receivable within one year 40/41 €35,279 €34,318 -€961 -2.7%
Trade receivables 40 €35,279 €34,318 -€961 -2.7%
Cash at bank and in hand 54/58 €26,783 €29,891 +€3,107 +11.6%
Deferred charges and accrued income 490/1 €3,967 €3,959 -€8 -0.2%
Total equity and liabilities 10/49 €669,636 €593,057 -€76,579 -11.4%
Equity 10/15 €180,325 €154,269 -€26,056 -14.4%
Contributions 10/11 €50,000 €50,000 = 0.0%
Reserves 13 €5,000 €5,000 = 0.0%
Distributable reserves 133 €5,000 €5,000 = 0.0%
Profit (loss) carried forward 14 €125,325 €99,269 -€26,056 -20.8%
Provisions and deferred taxes 16 €100,483 €99,034 -€1,449 -1.4%
Provisions for liabilities and charges 160/5 €71,027 €71,027 = 0.0%
Pensions and similar obligations 160 €71,027 €71,027 = 0.0%
Deferred taxes 168 €29,456 €28,007 -€1,449 -4.9%
Amounts payable 17/49 €388,828 €339,754 -€49,074 -12.6%
Amounts payable after more than one year 17 €244,674 €175,645 -€69,029 -28.2%
Financial debts 170/4 €112,894 €65,688 -€47,206 -41.8%
Other amounts payable 178/9 €131,780 €109,957 -€21,823 -16.6%
Amounts payable within one year 42/48 €136,622 €151,494 +€14,872 +10.9%
Current portion of amounts payable after more than one year 42 €44,701 €46,107 +€1,405 +3.1%
Trade debts 44 €73,005 €69,686 -€3,319 -4.5%
Suppliers 440/4 €73,005 €69,686 -€3,319 -4.5%
Taxes, remuneration and social security 45 €18,915 €35,702 +€16,786 +88.7%
Taxes 450/3 €18,915 €35,702 +€16,786 +88.7%
Accrued charges and deferred income 492/3 €7,532 €12,614 +€5,082 +67.5%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €78,980 €78,946 -€34 0.0%
Other operating charges 640/8 €2,864 €2,957 +€93 +3.2%
Gross operating margin 9900 €91,505 €81,453 -€10,052 -11.0%
Operating profit (loss) 9901 €9,661 -€450 -€10,111
Financial income 75/76B - €196 +€196
Recurring financial income 75 - €196 +€196
Financial charges 65/66B €13,589 €10,792 -€2,798 -20.6%
Recurring financial charges 65 €13,589 €10,792 -€2,798 -20.6%
Profit (loss) for the period before taxes 9903 -€3,929 -€11,046 -€7,117 -181%
Transfer from deferred taxes 780 €1,449 €1,449 = 0.0%
Income taxes 67/77 €79,510 €16,459 -€63,052 -79.3%
Profit (loss) for the period 9904 -€81,990 -€26,056 +€55,935 +68.2%
Profit (loss) for the period to be appropriated 9905 -€81,990 -€26,056 +€55,935 +68.2%

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 26 October 2026 via checked.be.